Angiogenesis Analytics

0 followers


We strive to make prostate cancer diagnosis quicker, more affordable, and less invasive by pairing artificial intelligence technology with ultrasound imaging.

Industries

+3

Headquarters

Employees

Links

Org chart

Mark Bloemendaal
CEO - Founder

Mark Bloemendaal

Collapse
Armand Wemelsfelder
Principal Software Engineer
Frans van Belle
Shareholder